innovation for industry
Article | Micro-nanoelectronics
A unique interface between patients and the medical industry
Hub4aim has an unique proposal to manage the preindustrial
phase from the proof of concept to regulatory marking.
Although it is already used to treat certain skin cancers, photodynamic therapy cannot reach the deepest lesions. The micro needle patch patented by CEA-Leti and Inserm* overcomes this limitation. It could reach the market in 3 to 5 years.
Since September, CEA-Leti and startup Aryballe have been contributing to the European Rose project to design a miniaturized artificial nose.
In November 2013, IPRASENSE and Leti started an exclusive research cooperation for developing cell culture monitoring techniques based on Leti-patented Lensfree imaging technology.
Iprasense's new Cytonote Counter does more than let you observe cells in culture-it assesses cell viability, providing unparalleled precision and reproducibility.
The problem with implantable medical monitoring devices for organs like the eye, brain, or heart, is that the power sources are often larger than the actual sensors.
Nano-biotechnology PlatformClinatec Platform
Connected Health ＆ WellnessAgriculture, Food Industry ＆ Environment
Smart Medical Technologies
See all demos
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.